Encara no tenim significats per a "compete risk".
1Kaplan-Meier method, competing risk models and Cox proportional hazard models were used.
2These findings were robust to multiple sensitivity analyses and competing risk analysis.
3Competing risks methodology was used to estimate and compare cause-specific cumulative incidence.
4Survival estimates were derived using Cox regression and competing risk models.
5Cox proportional hazards model for competing risks were used for analyses.
6Competing risks methods were used to estimate the cumulative incidence of local failure.
7A multivariable analysis was conducted using competing risk regression in the prediction of PCSM.
8Cumulative incidence (CumI) of events was estimated in a competing risks framework.
9Probability of recurrence was calculated using the competing risks method.
10The cumulative risk of CNS progression was calculated using death as a competing risk.
11The predicted risk of developing diabetes was described as sub-hazard ratios using competing risk regression.
12OS was analysed using the Kaplan-Meier method and RFS was assessed using competing risk analysis.
13Competing risk analysis and proportional hazards models were used to examine LR, DR, and OS.
14Results were robust to various sensitivity analyses such as competing risk analysis and multiple imputation.
15Algorithms will be developed using competing risks survival analysis.
16Competing risk models assessed 90-day cumulative incidence of deintensification.